Home › IGA Glomerulonephritis › Minnesota
IGA Glomerulonephritis clinical trials in Minnesota
3 studies for IGA Glomerulonephritis are looking for participants at sites in Minnesota.
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- Inter Med Consultants, Edina
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Aug 10, 2026 · NCT07146906Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of Minnesota, Masonic Children's Hospital, Minneapolis
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 3, 2025 · NCT06676579From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.